Dysfunctional uterine bleeding. Other specified abnormal uterine and vaginal bleeding
Conditions
Interventions
Intervention 1: Intervention group recive oral contraceptive pill plus Levothyroxin 50 microgram /day for 3 months . Intervention 2: Controlled group recive oral contraceptive pill plus placebo for 3
Treatment - Drugs
Placebo
Intervention group recive oral contraceptive pill plus Levothyroxin 50 microgram /day for 3 months .
Controlled group recive oral contraceptive pill plus placebo for 3 months.
Sponsors
Arak University Medical of Sciences
Eligibility
Sex/Gender
Female
Age
35 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age range 35 to 55 years and dysfunctional uterine bleeding. Exclusion criteria: pregnancy; diabetes mellitus; hyperprolactinemia; coagulopathy; uterine fibroma; endocervical and endometrial polyp; atypical hyperplasia or adenocarcinoma; ovarian cyst; ovarian mass; hormontherapy; thyroid dysfunction and contraindication of oral contraceptivpills .
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of uterine bleeding. Timepoint: Before intervention and at the end of intervention. Method of measurement: Clinical examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug side effects. Timepoint: Before intervention and every 1 month. Method of measurement: Clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehri Jamilian
Arak University of Medical Sciences
Outcome results
None listed